Immunoassays

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

The assay, based on the M5 and the M6 antibodies, measures total cell death due to apoptosis or necrosis and is intended for human serum or plasma.

The M30 CytoDeath™ ELISA offers a unique possibility to measure human cell death by apoptosis in cell cultures, multicellular spheroids and organ culture systems. The M30 CytoDeath™ ELISA is a product developed for cell culture applications, with a dynamic range and sensitivity suitable for in vitro work, making it a useful drug screening tool.

The M65 EpiDeath® ELISA represents the next generation of K18 positive biomarker assays.

The M65 EpiRat™ ELISA is based on the M5 and M6 antibodies, which bind to the biomarker Keratin-18 (K18). K18 is an intermediate filament protein in epithelial cells.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

The picoAMH ELISA is an enzyme-linked immunosorbent assay (ELISA) for the quantitative measurement of anti-Müllerian hormone (AMH), also known as Müllerian Inhibiting Substance (MIS), concentrations in human serum, Li-Heparin and K2 EDTA plasma.

The PAPP-A enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of PAPP-A in serum and other biological fluids. This assay is intended for in vitro diagnostic use.

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.